Ruan, Maomei <br/><br/>
Iodide- and glucose-handling gene expression regulated by sorafenib or cabozantinib in papillary thyroid cancer.  [electronic resource] 

 -  The Journal of clinical endocrinology and metabolism  May 2015 
 - 1771-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1945-7197 
<br/><br/><label>Standard No.: </label>10.1210/jc.2014-3023  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anilides--pharmacology<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Autoantigens--genetics<br/>Carcinoma, Papillary--drug therapy<br/>Cell Cycle--drug effects<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Glucose Transporter Type 1--genetics<br/>Glucose Transporter Type 3--genetics<br/>Humans<br/>Iodide Peroxidase--genetics<br/>Iron-Binding Proteins--genetics<br/>Microfilament Proteins--genetics<br/>Muscle Proteins--genetics<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds--pharmacology<br/>Phosphorylation--drug effects<br/>Protein Kinase Inhibitors--pharmacology<br/>Proto-Oncogene Proteins c-akt--genetics<br/>Proto-Oncogene Proteins c-ret--genetics<br/>Pyridines--pharmacology<br/>Receptors, Thyrotropin--genetics<br/>Signal Transduction--drug effects<br/>Sorafenib<br/>Symporters--genetics<br/>Thyroid Neoplasms--drug therapy